RE:18 million cancer patients globally O12009 wrote
If all goes well Theralase will be the front line treatment for many cancer indication. If they were able to treat a third of the patients @ $50000 a treatment that would equal 300 billion dollars per year. This is a real good time to load up on as many shares as you can handle.
Adding to that (TLT) sales from the equipment division to perform the treatment worldwide will also increase revenue. I would guess the company (TLT) will move into superstar status very quickly once CR numbers meet what we shareholders think will happen.